1. Evaluation of what matters most in existing clinical outcomes assessments in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020) Authors: Hartry, Ann; Menne, Heather; Wronski, Samantha L.; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; Hauber, Brett; DiBenedetti, Dana B. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quantifying what matters most to patients and care partners in Alzheimer's disease: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020) Authors: Hauber, Brett; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Hartry, Ann; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; DiBenedetti, Dana B. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The importance of care partner input in Alzheimer's disease (AD) drug development: Neuropsychiatry and behavioral neurology/treatment development and clinical trials. (7th December 2020) Authors: Majid, Tabassum; Paulsen, Russ; Callahan, Leigh F.; Potashman, Michele; Lee, Daniel; Hartry, Ann; Wunderlich, Glen; Hoffman, Deborah; Wieberg, Dan; Kremer, Ian N.; DiBenedetti, Dana B. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 6 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗